Human xenografts are not rejected in a naturally occurring immunodeficient porcine line: A human tumor model in pigs

BioResearch Open Access

Volumn 1, Issue 2, 2012, Pages 63-68

  Basel, Matthew T ^a   Balivada, Sivasai ^a   Beck, Amanda P ^a   Kerrigan, Maureen A ^a   Pyle, Marla M ^a   Dekkers, Jack C M ^b   Wyatt, Carol R ^a   Rowland, Robert R R ^a   Anderson, David E ^a   Bossmann, Stefan H ^a   Troyer, Deryl L ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Immunodeficient swine; Large animal cancer model; Melanoma; Pancreatic carcinoma; Xenografts

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA CELL; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; SWINE; TUMOR MODEL; TUMOR XENOGRAFT; WILD TYPE;

EID: 84901001448     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.9902     Document Type: Article

References (15)

1. Rothenberg ML, Carbone DP, Johnson DH. Improving the evaluation of new cancer treatments: challenges and opportunities. Nat Rev Cancer. 2003, 3:303-309.
2. Richmand A, Su Y. Mouse xenograft models vs gem models for human cancer therapeutics. Dis Models Mech. 2008, 1:78-82.
3. Kelland LR. "Of mice and men": values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer. 2004, 40:827-836.
4. Liu M, Hicklin D. Human tumor xenograft efficacy models. In: TumorModels in Cancer Research. Teicher BA. (ed.) Springer: New York, pp. 99-124, 2010.
5. Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer Res. 2006, 66:3351-3354.
6. Garber K. Realistic rodents? Debate grows over new mouse models of cancer. J Natl Cancer Inst. 2006, 98:1176-1178.
7. Sharpless NE, DePinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov. 2006, 5:741-754.
8. Schook L. Swine in biomedical research: creating the building blocks of animalmodels. Anim Biotechnol. 2005, 16:183-190.
9. Swanson KS, Mazur MJ, Vashisht K, et al. Genomics and clinical medicine: rationale for creating and effectively evaluating animal models. Ex Biol Med. 2004, 229:866-875.
10. Duran-Struuck R, Cho PS, Teague AGS, et al. Myelogenous leukemia in adult inbred mhc defined miniature swine: a model for human myeloid leukemias. Vet Immunol Immunopathol. 2010, 135:243-256.
11. Cho PS, Lo DP, Wikiel KJ, et al. Establishment of transplantable porcine tumor cell lines derived from mhc-inbred miniature swine. Blood. 2007, 110:3996-4004.
12. Adam SJ, Rund LA, Kuzmuk KN, et al. Genetic induction of tumorigenesis in swine. Oncogene. 2007, 26:1038-1045.
13. Finnie NJ, Gottlieb TM, Blunt T, et al. DNA-dependent protein kinase defects are linked to deficiencies in DNA repair and v(d)j recombination. Philos Trans R Soc Lond Ser B Biol Sci. 1996, 351:173-179.
14. Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010, 125:S182-S194.
15. Cino Ozuna A, Rowland R, Nietfeld J, et al. Lymphoid hypoplasia and absence of a specific antibody response in pigs: a suspected primary immunodeficiency disorder. Vet Pathol (in revision) 2012.